Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Diabetes

Trialing precision medicine for type 2 diabetes

A study prospectively evaluating a stratified approach to selecting treatment heralds a new era of precision medicine for type 2 diabetes, which should incorporate ongoing discovery, social determinants of health and healthcare transformation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Solving the puzzle of precision medicine for type 2 diabetes.

References

  1. Philipson, L. H. Nat. Rev. Endocrinol. 16, 79–80 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Davies, M. J. et al. Diabetes Care 45, 2753–2786 (2022).

    Article  CAS  PubMed  Google Scholar 

  3. Shields, B. M. et al. Nat. Med. https://doi.org/10.1038/s41591-022-02120-7 (2022).

    Article  PubMed  Google Scholar 

  4. Shields, B. M. et al. Nat. Med. https://doi.org/10.1038/s41591-022-02121-6 (2022).

    Article  PubMed  Google Scholar 

  5. Brankovic, M. et al. Eur. J. Clin. Invest. 49, e13145 (2019).

    Article  PubMed  Google Scholar 

  6. Schernthaner, G. et al. Diabetes Care 36, 2508–2515 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Neuen, B. L. et al. Lancet Diabetes Endocrinol. 7, 845–854 (2019).

    Article  CAS  PubMed  Google Scholar 

  8. Zinman, B. et al. Diabetes Care 41, 1783–1791 (2018).

    Article  CAS  PubMed  Google Scholar 

  9. Inzucchi, S. E. et al. Diabetes Care 41, 356–363 (2018).

    Article  CAS  PubMed  Google Scholar 

  10. Buse, J. B. et al. Diabetes Care 43, 1546–1552 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Frías, J. P. et al. N. Engl. J. Med. 385, 503–515 (2021).

    Article  PubMed  Google Scholar 

  12. Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the Quality Chasm: a New Health System for the 21st Century (National Academies Press, 2001).

  13. Duan, N., Kravitz, R. L. & Schmid, C. H. J. Clin. Epidemiol. 66, S21–S28 (2013).

Download references

Acknowledgements

S.J.P. was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K23DK128572). N.M.M. was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK126825).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nisa M. Maruthur.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pilla, S.J., Mathioudakis, N.N. & Maruthur, N.M. Trialing precision medicine for type 2 diabetes. Nat Med 29, 309–310 (2023). https://doi.org/10.1038/s41591-022-02168-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-022-02168-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing